Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preventive use of a hepatoprotectant against anti-tuberculosis drug-induced liver injury: A randomized controlled trial
Authors
Keywords
-
Journal
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume 31, Issue 2, Pages 409-416
Publisher
Wiley
Online
2015-08-04
DOI
10.1111/jgh.13070
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Preventive use of hepatoprotectors yields limited efficacy on the liver toxicity of anti-tuberculosis agents in a large cohort of Chinese patients
- (2015) Shanshan Wu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Use of Hy's Law and a New Composite Algorithm to Predict Acute Liver Failure in Patients With Drug-Induced Liver Injury
- (2014) Mercedes Robles–Diaz et al. GASTROENTEROLOGY
- Potential protection of vitamin C against liver-lesioned mice
- (2014) Min Su et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Global Epidemiology of Tuberculosis
- (2014) P. Glaziou et al. Cold Spring Harbor Perspectives in Medicine
- Current Challenges and Controversies in Drug-Induced Liver Injury
- (2013) Alberto Corsini et al. DRUG SAFETY
- Anti-Tuberculosis Drug-Induced Liver Injury in Shanghai: Validation of Hy’s Law
- (2013) Xin Shen et al. DRUG SAFETY
- Analysis of the economic burden of diagnosis and treatment of tuberculosis patients in rural China
- (2013) H-Q. Pan et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Silymarin for HCV infection
- (2012) Stephen J Polyak et al. ANTIVIRAL THERAPY
- Spontaneously Reported Hepatic Adverse Drug Events in Korea: Multicenter Study
- (2012) Hee Kwon et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase
- (2012) Hui-Min Xu WORLD JOURNAL OF GASTROENTEROLOGY
- Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH)
- (2011) Paul B. Watkins et al. DRUG SAFETY
- Incidence, Clinical Features and Impact on Anti-Tuberculosis Treatment of Anti-Tuberculosis Drug Induced Liver Injury (ATLI) in China
- (2011) Penghui Shang et al. PLoS One
- What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI)
- (2011) Helmi M’Kada et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Incidence, Clinical and Epidemiological Risk Factors, and Outcome of Drug-Induced Hepatitis Due to Antituberculous Agents in New Tuberculosis Cases
- (2010) Parvaneh Baghaei et al. AMERICAN JOURNAL OF THERAPEUTICS
- Design of the Anti-tuberculosis Drugs induced Adverse Reactions in China National Tuberculosis Prevention and Control Scheme Study (ADACS)
- (2010) Yin Yin Xia et al. BMC PUBLIC HEALTH
- Milk thistle in liver diseases: past, present, future
- (2010) Ludovico Abenavoli et al. PHYTOTHERAPY RESEARCH
- Biomarkers for drug-induced liver injury
- (2010) Qiang Shi et al. Expert Review of Gastroenterology & Hepatology
- Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study
- (2009) Weiguo Xu et al. BMC HEALTH SERVICES RESEARCH
- Prevention of hepatotoxicity due to anti tuberculosis treatment: A novel integrative approach
- (2008) Meghna R Adhvaryu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Antituberculosis drug-induced hepatotoxicity: Concise up-to-date review
- (2007) Alma Tostmann et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started